Overview

The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels

Status:
RECRUITING
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, single-center Phase IIa clinical study.
Phase:
PHASE2
Details
Lead Sponsor:
Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.
Collaborator:
Guangdong Provincial Hospital for Occupational Disease Prevention and Treatment
Treatments:
Injections
Sodium Chloride